Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures

被引：51

作者：

Carnio, Simona ^{[1
]}

Novello, Silvia ^{[1
]}

Papotti, Mauro ^{[1
]}

Loiacono, Marco ^{[1
]}

Scagliotti, Giorgio Vittorio ^{[1
]}

机构：

[1] Univ Torino, Dept Oncol, Turin, Italy

来源：

TRANSLATIONAL LUNG CANCER RESEARCH | 2013年 / 2卷 / 05期

关键词：

Prognostic and predictive biomarkers; early stages; non-small cell lung cancer (NSCLC); gene signatures;

D O I：

10.3978/j.issn.2218-6751.2013.10.05

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In early stage non-small cell lung cancer (NSCLC) large randomized trials have demonstrated that in patients with radically resected disease adjuvant chemotherapy improves 5-year survival rates. However, a customization of systemic treatment is needed to avoid treatments in patients cured by surgery alone or to justify the use of adjuvant chemotherapy in high risk patients, including those in stage IA. Recently, the possibility of identifying prognostic and predictive factors related to the genetic signatures of the tumor that could affect adjuvant and neo-adjuvant treatment choices for resectable non-small cell lung cancer (NSCLC) has been of interest. This review summarizes the current status and future opportunities for clinical application of genotyping and genomic tests in early NSCLC.

引用

页码：372 / 381

页数：10

共 88 条

[31] Higher Expression of Chemokine Receptor CXCR7 Is Linked to Early and Metastatic Recurrence in Pathological Stage I Nonsmall Cell Lung Cancer [J].

Iwakiri, Shotaro ;

Mino, Nobuya ;

Takahashi, Tsuyoshi ;

Sonobe, Makoto ;

Nagai, Shinjiro ;

Okubo, Kenichi ;

Wada, Hiromi ;

Date, Hiroshi ;

Miyahara, Ryo .

CANCER, 2009, 115 (11) :2580-2593

[32]

JOHNSTON PG, 1995, CANCER RES, V55, P1407

[33] MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer [J].

Kamal, Nermine S. ;

Soria, Jean-Charles ;

Mendiboure, Jean ;

Planchard, David ;

Olaussen, Ken A. ;

Rousseau, Vanessa ;

Popper, Helmut ;

Pirker, Robert ;

Bertrand, Pascale ;

Dunant, Ariane ;

Le Chevalier, Thierry ;

Filipits, Martin ;

Fouret, Pierre .

CLINICAL CANCER RESEARCH, 2010, 16 (04) :1206-1215

[34] Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer [J].

Ko, Eunkyung ;

Kim, Yujin ;

Park, Seong-Eun ;

Cho, Eun Yoon ;

Han, Jungho ;

Shim, Young Mog ;

Park, Joobae ;

Kim, Duk-Hwan .

LUNG CANCER, 2012, 77 (02) :401-406

[35] Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma [J].

Kosaka, Takayuki ;

Yatabe, Yasushi ;

Onozato, Ryoichi ;

Kuwano, Hiroyuki ;

Mitsudomi, Tetsuya .

JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (01) :22-29

[36] A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies [J].

Kratz, Johannes R. ;

He, Jianxing ;

Van den Eeden, Stephen K. ;

Zhu, Zhi-Hua ;

Gao, Wen ;

Pham, Patrick T. ;

Mulvihill, Michael S. ;

Ziaei, Fatemeh ;

Zhang, Huanrong ;

Su, Bo ;

Zhi, Xiuyi ;

Quesenberry, Charles P. ;

Habel, Laurel A. ;

Deng, Qiuhua ;

Wang, Zongfei ;

Zhou, Jiangfen ;

Li, Huiling ;

Huang, Mei-Chun ;

Yeh, Che-Chung ;

Segal, Mark R. ;

Ray, M. Roshni ;

Jones, Kirk D. ;

Raz, Dan J. ;

Xu, Zhidong ;

Jahan, Thierry M. ;

Berryman, David ;

He, Biao ;

Mann, Michael J. ;

Jablons, David M. .

LANCET, 2012, 379 (9818) :823-832

[37]

Lau CL, 2000, LUNG CANC PRINCIPLES, P602

[38] Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer [J].

Le Chevalier, T ;

Arriagada, R ;

Le Péchoux, C ;

Grunenwald, D ;

Dunant, A ;

Pignon, JP ;

Tarayre, M ;

Abratt, R ;

Arriagada, R ;

Bergman, B ;

Gralla, R ;

Grunenwald, D ;

Le Chevalier, T ;

Orlowski, T ;

Papadakis, E ;

Pinel, MIS ;

Araujo, C ;

Della Torre, H ;

de Solchaga, MM ;

Abdi, E ;

Blum, R ;

Ball, D ;

Basser, R ;

De Boer, R ;

Bishop, J ;

Brigham, B ;

Davis, S ;

Fox, D ;

Richardson, G ;

Wyld, D ;

Pirker, R ;

Humblet, Y ;

Delaunois, L ;

Van Meerbeeck, JP ;

Germonpre, P ;

Vansteenkiste, J ;

Nackaerts, K ;

Pinel, MIS ;

Vauthier, G ;

Younes, RN ;

Arriagada, R ;

Baeza, R ;

Carvajal, P ;

Kleinman, S ;

Orlandi, L ;

Castro, C ;

Godoy, J ;

Kosatova, K ;

Gaafar, R ;

Azarian, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04) :351-360

[39] Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin [J].

Leichman, CG ;

Lenz, HJ ;

Leichman, L ;

Danenberg, K ;

Baranda, J ;

Groshen, S ;

Boswell, W ;

Metzger, R ;

Tan, M ;

Danenberg, PV .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (10) :3223-3229

[40] Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer [J].

Liao, ML ;

Wang, HM ;

Lin, ZQ ;

Feng, JX ;

Zhu, DW .

LUNG CANCER, 2001, 33 (2-3) :125-132

← 1 2 3 4 5 6 7 8 9 →